Publication Information

{'id': 'https://openalex.org/W2621228630', 'doi': None, 'title': 'UJI AKTIVITAS ANTIINFLAMASI ASAM p-METOKSISINAMAT SISTEM SOLID LIPID NANOPARTICLES (SLN) DENGAN BASIS GEL CARBOMER ETD 2020 (Sistem SLN Setil Alkohol (10%) - Tween 80 (12%) Propilenglikol (20%))', 'display_name': 'UJI AKTIVITAS ANTIINFLAMASI ASAM p-METOKSISINAMAT SISTEM SOLID LIPID NANOPARTICLES (SLN) DENGAN BASIS GEL CARBOMER ETD 2020 (Sistem SLN Setil Alkohol (10%) - Tween 80 (12%) Propilenglikol (20%))', 'publication_year': 2012, 'publication_date': '2012-02-15', 'ids': {'openalex': 'https://openalex.org/W2621228630', 'mag': '2621228630'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://repository.unair.ac.id/9022/', 'pdf_url': None, 'source': None, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'dissertation', 'type_crossref': 'dissertation', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5013644807', 'display_name': 'Intan Primaning Tyas', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': True, 'raw_author_name': 'Intan Primaning Tyas', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A5013644807'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': None, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 64}, 'biblio': {'volume': None, 'issue': None, 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T14521', 'display_name': 'Medicinal Plant Research', 'score': 0.9857, 'subfield': {'id': 'https://openalex.org/subfields/1110', 'display_name': 'Plant Science'}, 'field': {'id': 'https://openalex.org/fields/11', 'display_name': 'Agricultural and Biological Sciences'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T14521', 'display_name': 'Medicinal Plant Research', 'score': 0.9857, 'subfield': {'id': 'https://openalex.org/subfields/1110', 'display_name': 'Plant Science'}, 'field': {'id': 'https://openalex.org/fields/11', 'display_name': 'Agricultural and Biological Sciences'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10704', 'display_name': 'Advancements in Transdermal Drug Delivery', 'score': 0.9355, 'subfield': {'id': 'https://openalex.org/subfields/3003', 'display_name': 'Pharmaceutical Science'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10920', 'display_name': 'Advanced Drug Delivery Systems', 'score': 0.9068, 'subfield': {'id': 'https://openalex.org/subfields/3003', 'display_name': 'Pharmaceutical Science'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/solid-lipid-nanoparticle', 'display_name': 'Solid lipid nanoparticle', 'score': 0.9895272}], 'concepts': [{'id': 'https://openalex.org/C199529486', 'wikidata': 'https://www.wikidata.org/wiki/Q7557912', 'display_name': 'Solid lipid nanoparticle', 'level': 3, 'score': 0.9895272}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.6623167}, {'id': 'https://openalex.org/C2779820397', 'wikidata': 'https://www.wikidata.org/wiki/Q1392806', 'display_name': 'Drug delivery', 'level': 2, 'score': 0.51338494}, {'id': 'https://openalex.org/C43617362', 'wikidata': 'https://www.wikidata.org/wiki/Q170050', 'display_name': 'Chromatography', 'level': 1, 'score': 0.44681364}, {'id': 'https://openalex.org/C13965031', 'wikidata': 'https://www.wikidata.org/wiki/Q243545', 'display_name': 'Nuclear chemistry', 'level': 1, 'score': 0.37003464}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.33501107}, {'id': 'https://openalex.org/C178790620', 'wikidata': 'https://www.wikidata.org/wiki/Q11351', 'display_name': 'Organic chemistry', 'level': 1, 'score': 0.22908622}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.11674857}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://repository.unair.ac.id/9022/', 'pdf_url': None, 'source': None, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.77}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': [], 'abstract_inverted_index': {'The': [0, 45, 53], 'research': [1, 46], 'objective': [2], 'to': [3, 17, 91], 'investigate': [4], 'effect': [5, 55], 'of': [6, 48, 56, 80], 'Solid': [7, 22, 57], 'lipid': [8, 23], 'nanoparticles': [9, 24], '(SLN)': [10, 25], 'system': [11, 82], 'on': [12, 66, 83], 'p-Methoxycinnamic': [13], 'acid': [14], 'was': [15, 26], 'proposed': [16], 'have': [18], 'an': [19], 'antiinflamatory': [20, 51, 54, 78], 'activity.': [21], 'greatly': [27], 'investigated': [28], 'recently': [29], 'as': [30, 40], 'a': [31, 41], 'new': [32], 'drug': [33, 43], 'delivery': [34], 'system.': [35, 95], 'SLN': [36, 81, 94], 'had': [37], 'several': [38], 'benefits': [39], 'topical': [42], 'carrier.': [44], 'consist': [47], 'organoleptic,': [49], 'pH,': [50], 'effect.': [52], 'Lipid': [58], 'Nanoparticles': [59], 'were': [60], 'compared': [61, 90], 'with': [62], 'Diclofenac': [63], 'Na': [64], 'gel': [65], 'carragenan': [67], 'induced': [68], 'paw': [69], 'edema': [70], 'in': [71], 'rats.': [72], 'Antiinflamtory': [73], 'activity': [74, 79], 'test': [75], 'showed': [76], 'that': [77], 'APMS': [84, 92], 'did': [85], 'not': [86], 'gave': [87], 'signicant': [88], 'differences': [89], 'without': [93]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2621228630', 'counts_by_year': [], 'updated_date': '2024-12-12T17:57:21.770710', 'created_date': '2017-06-09'}